慢性鼻窦炎伴哮喘患者的临床控制与生活质量:内镜鼻窦手术效果的随机对照研究
一项随机对照试验纳入150例慢性鼻窦炎伴哮喘患者,等分为手术组与对照组,两组按年龄、性别、病程和鼻窦CT分级匹配。手术组症状评分、肺功能(FEV1、FVC、FEV1/FVC)、生活质量和炎症指标均显著改善,用药减少,不良事件率低(1%)。结论认为内镜鼻窦手术有效,支持其作为有益治疗。
要点
- 手术组所有症状评分均显著改善(P < .001)。
- 手术组FEV1、FVC及FEV1/FVC均显著高于对照组(P < .001)。
- 手术组RQLQ和AQLQ生活质量评分显著改善(P < .001)。
核心结论
- 内镜鼻窦手术可有效改善慢性鼻窦炎伴哮喘患者的临床结局和生活质量,减少炎症和用药需求,支持其作为有益治疗。
研究设计与样本
- 随机对照试验,纳入150例慢性鼻窦炎伴哮喘患者,等分为手术组和对照组。
- 参与者按年龄、性别、病程和鼻窦CT分级进行匹配。
- 采用计算机生成的表格进行随机分配。
主要发现
- 手术组所有症状评分指标均显著改善(P < .001)。
- 手术组FEV1、FVC和FEV1/FVC均显著高于对照组(P < .001)。
- 手术组RQLQ和AQLQ生活质量评分显著改善(P < .001)。
- 6个月时,肺功能与鼻窦CT分级之间存在相关性,分别为负相关和正相关(P < .05)。
- 炎症标志物和药物使用显著减少(P < .001,P < .05),不良事件率低(1%)。
关键数值与推荐
- 手术组症状评分改善P < .001。
- 手术组FEV1、FVC、FEV1/FVC高于对照组P < .001。
- 手术组RQLQ和AQLQ评分改善P < .001。
- 6个月时肺功能与鼻窦CT分级相关P < .05。
- 炎症标志物和药物使用减少P < .001和P < .05,不良事件率1%。
临床怎么用
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the impact of endoscopic sinus surgery (ESS) on chronic rhinosinusitis with asthma (CRSwA) patients' clinical control and quality of life. STUDY DESIGN: A randomized controlled trial involving 150 CRSwA patients, equally divided into surgical and control groups. SETTING: Participants were matched for age, gender, illness duration, and computed tomography (CT) grading of the sinuses. METHODS: Random allocation was conducted using a computer-generated table. RESULTS: The surgical group exhibited significant symptom score improvements across all metrics (P < .001). Lung function parameters showed substantial gains, with forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratios significantly higher than the control group (P < .001). Quality of life scores, measured by RQLQ and AQLQ, improved significantly in the surgical group (P < .001). At 6 months, correlations between lung function and CT grading of the sinuses were evident, with negative and positive correlations, respectively (P < .05). Inflammatory markers and medication usage were notably reduced (P < .001, P < .05), with low adverse event rates (1%). CONCLUSION: ESS is effective in enhancing clinical outcomes and quality of life for CRSwA patients, reducing inflammation and medication needs, thus supporting its use as a beneficial treatment.
引用
- Ma R. Clinical Control and Quality of Life in Patients With Chronic Rhinosinusitis With Asthma: A Study on the Effects of Endoscopic Sinus Surgery. Otolaryngol Head Neck Surg. 2024. PMID: 39529590. doi:10.1002/ohn.1040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。